#Cannabis
Testing Market to Reach $1.4 Billion by 2021 - Driven by Growing Number of
Cannabis Testing Laboratories
DUBLIN - March 31, 2017
(Investorideas.com Newswire) Research and Markets has announced the addition of
the "Cannabis Testing Market - Global Forecast to 2021" report to
their offering.
The global cannabis testing market is
expected to reach USD 1,416.3 Million by 2021 from USD 822.0 Million in 2016,
at a CAGR of 11.5% during the forecast period (2016-2021).
The growth in this market is mainly
driven by factors such as legalization of medical cannabis, coupled with the
growing number of cannabis testing laboratories (specifically in the U.S.);
growing adoption of LIMS in cannabis testing laboratories; and increasing
awareness through conferences, symposia, and workshops. On the other hand, the
high cost of analytical instruments, presence of alternative technologies, and
dearth of skilled professionals are some of the major factors that are expected
to restrain the growth of this market in the coming years.
This report segments the cannabis
testing market into cannabis testing products (analytical instruments and
consumables) & software (Cannabis LIMS), cannabis testing services, end
users, and regions. On the basis of products, the market is broadly categorized
into two segments, namely, analytical instruments and consumables. The
consumables segment is expected to grow at the highest CAGR during the forecast
period owing to their recurring requirement and repetitive usage.
Companies
Mentioned:
- AB Sciex LLC
- Accelerated Technology
Laboratories, Inc.
- Agilent Technologies, Inc.
- Digipath, Inc.
- Millipore Sigma
- Perkinelmer, Inc.
- Pharmlabs LLC
- Restek Corporation
- SC (Science of Cannabis)
Laboratories, Inc.
- Shimadzu Corporation
- Steep Hill Halent
Laboratories, Inc.
- Waters Corporation
Key Topics Covered:
- Introduction
- Research Methodology
- Executive Summary
- Premium Insights
- Market Overview
- Industry Insights
- Cannabis Testing Market, By
Product and Software
- Cannabis Testing Services
Market, By Type
- Cannabis Testing Market,By
End User
- Cannabis Testing Market, By
Region
- Competitive Landscape
- Company Profiles
- Appendix
For more information about this
report visit http://www.researchandmarkets.com/research/nzcslq/cannabis_testing
Media Contact:
Laura Wood, Senior Manager
press@researchandmarkets.com
press@researchandmarkets.com
For E.S.T Office Hours Call
1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Fax (outside U.S.): +353-1-481-1716
Watch the 420
Cannabis Investor video
More Info:
This news is published on the
Investorideas.com Newswire - a global digital news source for investors and
business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investment involves risk and possible loss of
investment. This site is currently compensated for news publication and
distribution, social media and marketing, content creation and more. Contact
each company directly regarding content and press release questions. Disclosure
is posted for each compensated news release, content published /created if
required but otherwise the news was not compensated for and was published for
the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.
Global investors must adhere to regulations of each country.
No comments:
Post a Comment